体内
抗辐射性
球体
化学
癌症研究
克隆形成试验
体外
放射治疗
纳米颗粒
放射增敏剂
纳米医学
生物物理学
旁观者效应
癌症
放射生物学
辐射耐受性
生物信息学
辐射敏感性
纳米技术
细胞生物学
模型系统
细胞存活
细胞培养
治疗窗口
癌细胞
剂量分馏
细胞生长
癌症治疗
作者
Lukas R. H. Gerken,Laurin G.S. Schaller,Rüveyda Dok,Selina Camenisch,Alexander Gogos,Sebastian Habermann,Sandra Nuyts,Inge Katrin Herrmann
标识
DOI:10.1021/acsabm.5c02153
摘要
Despite extensive efforts to develop nanoparticle-based radioenhancers, clinical translation remains limited, partly due to the lack of physiologically relevant preclinical models. To address this gap, we developed a 3D spheroid model of head and neck cancer using FaDu cells and compared it directly to a corresponding in vivo model in a radiotherapy setting. The spheroids exhibited key tumor-like features, including the formation of a hypoxic core and growth kinetics similar to those of in vivo tumors. Importantly, the model allowed for long-term monitoring of tumor growth and radiation response. Upon X-ray irradiation, the dose–response behavior in spheroids mirrored that observed in vivo. Furthermore, TiO 2, HfO 2, and Au nanoparticles demonstrated consistent radiosensitization effects in both systems when matched for the uptake mass. In contrast, conventional 2D clonogenic assays failed to align with in vivo performance, likely due to their lower radioresistance and unrealistic nanoparticle exposure conditions. This study introduces a robust, scalable, and clinically compatible 3D in vitro platform for the preclinical screening of nanoparticle radioenhancers. The system may offer streamlining of development pipelines and support the 3R principles of reduction, replacement, and refinement in radiation oncology research.
科研通智能强力驱动
Strongly Powered by AbleSci AI